Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Men with enlarged prostates often have more severe baldness.

Apoptosis contributes to hair loss in androgenetic alopecia.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

ATP-sensitive potassium channels are important for hair growth.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Berberine may reduce prostate enlargement by blocking inflammation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Baricitinib shows promise in treating severe hair loss.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

MCHR2 gene duplications may be linked to alopecia areata.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Abietic acid from pine rosin can effectively fight and reduce harmful skin microbes.

CEC levels may be a useful marker for predicting prostate cancer progression.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.